Starpharma signs new DEP® agreement with MSD |
| August 10, 2022 | August 2022 Bond Updates |
|
MELBOURNE, Australia, Aug. 10, 2022 /PRNewswire/ -- Australian biotechnology company Starpharma today announced it has signed a new DEP® Research Agreement with MSD, the trade name of Merck Sharp & Dohme LLC, Rahway, NJ, USA. This new DEP® program will generate and evaluate additional... |
| View more at: https://www.prnewswire.com:443/news-releases/starpharma-signs-new-dep-agreement-with-msd-301603282.html |